CCR2 and neoplasm: In mice implanted with HR+ breast tumors, estradiol also augmented CCL2 levels both in serum and in tumor itself, and blocking CCR2 by RS102895 significantly slowed estrogen-stimulated tumor growth and inhibited liver metastasis largely on account of decreased proliferative activity in tumor cells and reduced angiogenesis and macrophage infiltration in tumor stroma.